Journal article
Assessing the utility of testing aluminum levels in dialysis patients
AK Sharma, ND Toussaint, J Pickering, T Beeston, ER Smith, SG Holt
Hemodialysis International | WILEY | Published : 2015
DOI: 10.1111/hdi.12231
Abstract
Plasma aluminum (Al) is routinely tested in many dialysis patients. Aluminum exposure may lead to acute toxicity and levels in excess of ~2.2μmol/L (60μg/L) should be avoided. Historically, toxicity has been caused by excessive dialyzate Al but modern reverse osmosis (RO) water should be Al free. Nevertheless, many units continue to perform routine Al levels on dialysis patients. This single-center study retrospectively analyzed Al levels in plasma, raw water feed, and RO product between 2010 and 2013 using our database (Nephworks 6) with the aim of determining the utility of these measurements. Two thousand fifty-eight plasma Al tests in 755 patients (61.9% male, mean age 64.7 years) were r..
View full abstract